Eingabe löschen




Antibody discovery for therapy of pain

Auf einen Blick

  • Projektleiter/in : Prof. Dr. Jack Rohrer
  • Co-Projektleiter/in : Prof. Dr. Christiane Zaborosch
  • Stellv. Projektleiter/in : Dr. Bruno Filippi
  • Projektteam : Dr. David Urech
  • Projektvolumen : CHF 1'442'032
  • Projektstatus : abgeschlossen
  • Drittmittelgeber : KTI (KTI-Projekt / Projekt Nr. 13541.1;5 PFFLR-LS)
  • Projektpartner : Numab Therapeutics AG
  • Kontaktperson : Jack Rohrer


The aim fo this project ist the discovery of a novel and innovative product for the treatment of chronic severe pain. The anticipated product candidate will specifically block pain sensation without the oftentimes treatment limiting adverse effects of currently marketed products. To achieve this, a breakthrough antibody discovery technology shall be applied. Methods developed in this first part of the project shall be synergistically used for the discovery of a second antibody specifically targeting breast cancer metastasis.